{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:19:21Z","timestamp":1789172361083,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CSL Behring AG, Berne, Switzerland"},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["310030_197823"],"award-info":[{"award-number":["310030_197823"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013348","name":"Innosuisse - Schweizerische Agentur f\u00fcr Innovationsf\u00f6rderung","doi-asserted-by":"publisher","award":["36361 IP-LS"],"award-info":[{"award-number":["36361 IP-LS"]}],"id":[{"id":"10.13039\/501100013348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017659","name":"Uniscientia Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100017659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Forschungskredit of the University of Zurich","award":["21-021"],"award-info":[{"award-number":["21-021"]}]},{"name":"Forschungskredit of the University of Zurich","award":["20-025"],"award-info":[{"award-number":["20-025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Preclinical studies provided a strong rationale for a pathophysiological link between cell-free hemoglobin in the cerebrospinal fluid (CSF-Hb) and secondary brain injury after subarachnoid hemorrhage (SAH-SBI). In a single-center prospective observational clinical study, external ventricular drain (EVD) based CSF-Hb proved to be a promising biomarker to monitor for SAH-SBI. The primary objective of the HeMoVal study is to prospectively validate the association between EVD based CSF-Hb and SAH-SBI during the first 14\u2009days post-SAH. Secondary objectives include the assessment of the discrimination ability of EVD based CSF-Hb for SAH-SBI and the definition of a clinically relevant range of EVD based CSF-Hb toxicity. In addition, lumbar drain (LD) based CSF-Hb will be assessed for its association with and discrimination ability for SAH-SBI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>HeMoVal is a prospective international multicenter observational cohort study. Adult patients admitted with aneurysmal subarachnoid hemorrhage (aSAH) are eligible. While all patients with aSAH are included, we target a sample size of 250 patients with EVD within the first 14\u2009day after aSAH. Epidemiologic and disease-specific baseline measures are assessed at the time of study inclusion. In patients with EVD or LD, each day during the first 14\u2009days post-SAH, 2\u2009ml of CSF will be sampled in the morning, followed by assessment of the patients for SAH-SBI, co-interventions, and complications in the afternoon. After 3 months, a clinical follow-up will be performed. For statistical analysis, the cohort will be stratified into an EVD, LD and full cohort. The primary analysis will quantify the strength of association between EVD based CSF-Hb and SAH-SBI in the EVD cohort based on a generalized additive model. Secondary analyses include the strength of association between LD based CSF-Hb and SAH-SBI in the LD cohort based on a generalized additive model, as well as the discrimination ability of CSF-Hb for SAH-SBI based on receiver operating characteristic (ROC) analyses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>We hypothesize that this study will validate the value of CSF-Hb as a biomarker to monitor for SAH-SBI. In addition, the results of this study will provide the potential base to define an intervention threshold for future studies targeting CSF-Hb toxicity after aSAH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Study registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov Identifier <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04998370\">NCT04998370<\/jats:ext-link>. Date of registration: August 10, 2021.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-022-02789-w","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T07:02:44Z","timestamp":1658127764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The HeMoVal study protocol: a prospective international multicenter cohort study to validate cerebrospinal fluid hemoglobin as a monitoring biomarker for aneurysmal subarachnoid hemorrhage related secondary brain injury"],"prefix":"10.1186","volume":"22","author":[{"given":"Kevin","family":"Akeret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael M.","family":"Buzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Saxenhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Bieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Chiavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart R.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Gr\u00fcttner-Durmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Schwendinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rok","family":"Humar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Regli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan P. C.","family":"van Doormaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3057-0472","authenticated-orcid":false,"given":"Michael","family":"Hugelshofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik J.","family":"Schaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"HeMoVal Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Zuercher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Grob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Abdulazim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil","family":"Gr\u00fcter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Roder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Wirz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit A.","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Hostettler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"H\u00e4gler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Etminan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Helmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Bozinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gentinetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincens","family":"K\u00e4lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"key":"2789_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrneurol.2013.246","volume":"10","author":"RL Macdonald","year":"2014","unstructured":"Macdonald RL. Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol. 2014;10:44\u201358.","journal-title":"Nat Rev Neurol"},{"key":"2789_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0967-5868(94)90005-1","volume":"1","author":"NWC Dorsch","year":"1994","unstructured":"Dorsch NWC, King MT. A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage part I: incidence and effects. J Clin Neurosci. 1994;1:19\u201326.","journal-title":"J Clin Neurosci"},{"key":"2789_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/bja\/aes264","volume":"109","author":"MJ Rowland","year":"2012","unstructured":"Rowland MJ, Hadjipavlou G, Kelly M, Westbrook J, Pattinson KTS. Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm. Br J Anaesth. 2012;109:315\u201329.","journal-title":"Br J Anaesth"},{"key":"2789_CR4","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1136\/jnnp.51.11.1457","volume":"51","author":"GM Teasdale","year":"1988","unstructured":"Teasdale GM, Drake CG, Hunt W, Kassell N, Sano K, Pertuiset B, et al. A universal subarachnoid hemorrhage scale: report of a committee of the world federation of neurosurgical societies. J Neurol Neurosurg Psychiatry. 1988;51:1457.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2789_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3171\/jns.1968.28.1.0014","volume":"28","author":"WE Hunt","year":"1968","unstructured":"Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28:14\u201320.","journal-title":"J Neurosurg"},{"key":"2789_CR6","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1227\/NEU.0b013e318267360f","volume":"71","author":"DA Wilson","year":"2012","unstructured":"Wilson DA, Nakaji P, Abla AA, Uschold TD, Fusco DJ, Oppenlander ME, et al. A simple and quantitative method to predict symptomatic vasospasm after subarachnoid hemorrhage based on computed tomography: beyond the Fisher scale. Neurosurgery. 2012;71:869\u201375.","journal-title":"Neurosurgery."},{"key":"2789_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1227\/00006123-198001000-00001","volume":"6","author":"CM Fisher","year":"1980","unstructured":"Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980;6:1\u20139.","journal-title":"Neurosurgery."},{"key":"2789_CR8","first-page":"21","volume":"59","author":"JA Frontera","year":"2006","unstructured":"Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly ES, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage. The modified Fisher scale Neurosurgery. 2006;59:21\u20137.","journal-title":"The modified Fisher scale Neurosurgery"},{"key":"2789_CR9","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","volume":"43","author":"ES Connolly Jr","year":"2012","unstructured":"Connolly ES Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/american Stroke Association. Stroke. 2012;43:1711\u201337.","journal-title":"Stroke."},{"key":"2789_CR10","doi-asserted-by":"crossref","unstructured":"Diringer MN, Bleck TP, Claude Hemphill J, 3rd, Menon D, Shutter L, Vespa P, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical care Society\u2019s multidisciplinary consensus conference. Neurocrit Care. 2011;15:211\u201340.","DOI":"10.1007\/s12028-011-9605-9"},{"key":"2789_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/STROKEAHA.112.674291","volume":"44","author":"NK Rooij","year":"2013","unstructured":"Rooij NK, Gje R, Jw D, Cjm F. Delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review of clinical, laboratory, and radiological predictors. Stroke. 2013;44:43\u201354.","journal-title":"Stroke."},{"key":"2789_CR12","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1177\/0271678X211020629","volume":"41","author":"K Akeret","year":"2021","unstructured":"Akeret K, Buzzi RM, Schaer CA, Thomson BR, Vallelian F, Wang S, et al. Cerebrospinal fluid hemoglobin drives subarachnoid hemorrhage-related secondary brain injury. J Cereb Blood Flow Metab. 2021;41:3000\u201315.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2789_CR13","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1172\/JCI130630","volume":"129","author":"M Hugelshofer","year":"2019","unstructured":"Hugelshofer M, Buzzi RM, Schaer CA, Richter H, Akeret K, Anagnostakou V, et al. Haptoglobin administration into the subarachnoid space prevents hemoglobin-induced cerebral vasospasm. J Clin Invest. 2019;129:5219\u201335.","journal-title":"J Clin Invest"},{"key":"2789_CR14","doi-asserted-by":"publisher","first-page":"fcz053","DOI":"10.1093\/braincomms\/fcz053","volume":"2","author":"P Garland","year":"2020","unstructured":"Garland P, Morton MJ, Haskins W, Zolnourian A, Durnford A, Gaastra B, et al. Haemoglobin causes neuronal damage in vivo which is preventable by haptoglobin. Brain Commun. 2020;2:fcz053.","journal-title":"Brain Commun"},{"key":"2789_CR15","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2021","unstructured":"R Core Team (2021). R: a language and environment for statistical computing."},{"key":"2789_CR16","unstructured":"Bland M. An introduction to medical statistics: Oxford University Press; 2015."},{"key":"2789_CR17","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453\u20137.","journal-title":"Lancet."},{"key":"2789_CR18","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","volume":"41","author":"MDI Vergouwen","year":"2010","unstructured":"Vergouwen MDI, Vermeulen M, van Gijn J, Rinkel GJE, Wijdicks EF, Muizelaar JP, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41:2391\u20135.","journal-title":"Stroke."},{"key":"2789_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12987-020-00205-4","volume":"17","author":"J Bergman","year":"2020","unstructured":"Bergman J, Svenningsson A, Liv P, Bergenheim T, Burman J. Location matters: highly divergent protein levels in samples from different CNS compartments in a clinical trial of rituximab for progressive MS. Fluids Barriers CNS. 2020;17:49.","journal-title":"Fluids Barriers CNS"},{"key":"2789_CR20","unstructured":"Hastie TJ, Tibshirani RJ. Generalized additive models: CRC Press; 1990."},{"key":"2789_CR21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1056\/NEJM198403013100903","volume":"310","author":"CG Mayhall","year":"1984","unstructured":"Mayhall CG, Archer NH, Lamb VA, Spadora AC, Baggett JW, Ward JD, et al. Ventriculostomy-related infections. A prospective epidemiologic study. N Engl J Med. 1984;310:553\u20139.","journal-title":"N Engl J Med"},{"key":"2789_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12028-015-0224-8","volume":"24","author":"HI Fried","year":"2016","unstructured":"Fried HI, Nathan BR, Rowe AS, Zabramski JM. The insertion and management of external ventricular drains: an evidence-based consensus statement. Neurocrit Care. 2016;24:61\u201381.","journal-title":"Neurocrit Care"},{"key":"2789_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/jnnp-2017-316415","volume":"89","author":"AAB Jamjoom","year":"2018","unstructured":"Jamjoom AAB, Joannides AJ, Poon MT-C, Chari A, Zaben M, Abdulla MAH, et al. Prospective, multicentre study of external ventricular drainage-related infections in the UK and Ireland. J Neurol Neurosurg Psychiatry. 2018;89:120\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2789_CR24","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3171\/jns.2003.98.4.0725","volume":"98","author":"JM Zabramski","year":"2003","unstructured":"Zabramski JM, Whiting D, Darouiche RO, Horner TG, Olson J, Robertson C, et al. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg. 2003;98:725\u201330.","journal-title":"J Neurosurg"},{"key":"2789_CR25","first-page":"1064","volume":"81","author":"GK Wong","year":"2010","unstructured":"Wong GK, Ip M, Poon WS, Mak CW, Ng RY. Antibiotics-impregnated ventricular catheter versus systemic antibiotics forprevention of nosocomial CSF and non-CSF infections: aprospective randomised clinical trial. 2010;81:1064\u20137.","journal-title":"Antibiotics-impregnated ventricular catheter versus systemic antibiotics forprevention of nosocomial CSF and non-CSF infections: aprospective randomised clinical trial."},{"key":"2789_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1227\/01.NEU.0000370247.11479.B6","volume":"67","author":"JS Harrop","year":"2010","unstructured":"Harrop JS, Sharan AD, Ratliff J. Impact of a standardizedprotocol and antibiotic-impregnated catheteis on ventriculostomyinfection rates in cerebrovascular patients. Neurosurgery. 2010;67:187\u201391.","journal-title":"Neurosurgery."},{"key":"2789_CR27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1227\/NEU.0b013e3182039a14","volume":"68","author":"AA Abla","year":"2011","unstructured":"Abla AA, Zabramski JM, Jahnke HK, Fusco D, Nakaji P. Comparison of two antibiotic-impregnated ventricular catheters:a prospective sequential series trial. Neurosurgery. 2011;68:437\u201342.","journal-title":"Neurosurgery."},{"key":"2789_CR28","first-page":"514","volume":"118","author":"Z Kubilay","year":"2013","unstructured":"Kubilay Z, Amini S, Fauerbach LL, Archibald L, Friedman WA, Layon AJ. Decreasing ventricular infections through the use of aventriculostomy placement bundle: experience at a single institution. 2013;118:514\u201320.","journal-title":"Decreasing ventricular infections through the use of aventriculostomy placement bundle: experience at a single institution."},{"key":"2789_CR29","first-page":"1041","volume":"56","author":"CA Sloffer","year":"2005","unstructured":"Sloffer CA, Augspurger L, Wagenbach A, Lanzino G. Antimi-crobial-impregnated external ventricular catheters: does the verylow infection rate observed in clinical trials apply to dailyclinical practice? Neurosurgery. 2005;56:1041\u20134.","journal-title":"Neurosurgery."},{"key":"2789_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/02688697.2020.1725436","volume":"34","author":"SS Talibi","year":"2020","unstructured":"Talibi SS, Silva AH, Afshari FT, Hodson J, Roberts SA, Oppenheim B, et al. The implementation of an external ventricular drain care bundle to reduce infection rates. Br J Neurosurg. 2020;34:181\u20136.","journal-title":"Br J Neurosurg"},{"key":"2789_CR31","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00701-019-03801-y","volume":"161","author":"K Hussein","year":"2019","unstructured":"Hussein K, Rabino G, Feder O, Eghbaryeh H, Zayyad H, Sviri G, et al. Risk factors for meningitis in neurosurgical patients with cerebrospinal fluid drains: prospective observational cohort study. Acta Neurochir. 2019;161:517\u201324.","journal-title":"Acta Neurochir"},{"key":"2789_CR32","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s15010-010-0006-3","volume":"38","author":"S Scheithauer","year":"2010","unstructured":"Scheithauer S, B\u00fcrgel U, Bickenbach J, H\u00e4fner H, Haase G, Waitschies B, et al. External ventricular and lumbar drainage-associated meningoventriculitis: prospective analysis of time-dependent infection rates and risk factor analysis. Infection. 2010;38:205\u20139.","journal-title":"Infection"},{"key":"2789_CR33","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00701-018-3508-x","volume":"160","author":"DR Thompson","year":"2018","unstructured":"Thompson DR, Vlachos S, Patel S, Innocent S, Tolias C, Barkas K. Recurrent sampling and ventriculostomy-associated infections: a case-control study. Acta Neurochir. 2018;160:1089\u201396.","journal-title":"Acta Neurochir"},{"key":"2789_CR34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12028-015-0239-1","volume":"25","author":"H Liang","year":"2016","unstructured":"Liang H, Zhang L, Gao A, Li Y, Jiang Z, Hu F, et al. Risk factors for infections related to lumbar drainage in spontaneous subarachnoid hemorrhage. Neurocrit Care. 2016;25:243\u20139.","journal-title":"Neurocrit Care"},{"key":"2789_CR35","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3171\/2011.6.JNS11167","volume":"115","author":"TA Williams","year":"2011","unstructured":"Williams TA, Leslie GD, Dobb GJ, Roberts B, van Heerden PV. Decrease in proven ventriculitis by reducing the frequency of cerebrospinal fluid sampling from extraventricular drains: clinical article. J Neurosurg. 2011;115:1040\u20136.","journal-title":"J Neurosurg"},{"key":"2789_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00701-007-1458-9","volume":"150","author":"D Hoefnagel","year":"2008","unstructured":"Hoefnagel D, Dammers R, Ter Laak-Poort MP, Avezaat CJJ. Risk factors for infections related to external ventricular drainage. Acta Neurochir. 2008;150:209\u201314 discussion 214.","journal-title":"Acta Neurochir"},{"key":"2789_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ajic.2004.11.008","volume":"33","author":"Y Arabi","year":"2005","unstructured":"Arabi Y, Memish ZA, Balkhy HH, Francis C, Ferayan A, Al Shimemeri A, et al. Ventriculostomy-associated infections: incidence and risk factors. Am J Infect Control. 2005;33:137\u201343.","journal-title":"Am J Infect Control"},{"key":"2789_CR38","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1086\/324492","volume":"33","author":"KE Lyke","year":"2001","unstructured":"Lyke KE, Obasanjo OO, Williams MA, O\u2019Brien M, Chotani R, Perl TM. Ventriculitis complicating use of intraventricular catheters in adult neurosurgical patients. Clin Infect Dis. 2001;33:2028\u201333.","journal-title":"Clin Infect Dis"},{"key":"2789_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/BF01420503","volume":"83","author":"E Stenager","year":"1986","unstructured":"Stenager E, Gerner-Smidt P, Kock-Jensen C. Ventriculostomy-related infections--an epidemiological study. Acta Neurochir. 1986;83:20\u20133.","journal-title":"Acta Neurochir"},{"key":"2789_CR40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3171\/2009.6.JNS09223","volume":"112","author":"MA Leverstein-van Hall","year":"2010","unstructured":"Leverstein-van Hall MA, Hopmans TEM, van der Sprenkel JWB, Blok HEM, van der Mark WAMA, Hanlo PW, et al. A bundle approach to reduce the incidence of external ventricular and lumbar drain-related infections. J Neurosurg. 2010;112:345\u201353.","journal-title":"J Neurosurg"},{"key":"2789_CR41","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.3171\/2018.1.JNS172486","volume":"130","author":"J Champey","year":"2018","unstructured":"Champey J, Mourey C, Francony G, Pavese P, Gay E, Gergele L, et al. Strategies to reduce external ventricular drain\u2013related infections: a multicenter retrospective study. J Neurosurg. 2018;130:2034\u20139.","journal-title":"J Neurosurg"},{"key":"2789_CR42","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3109\/02688697.2011.578770","volume":"25","author":"WJ Kitchen","year":"2011","unstructured":"Kitchen WJ, Singh N, Hulme S, Galea J, Patel HC, King AT. External ventricular drain infection: improved technique can reduce infection rates. Br J Neurosurg. 2011;25:632\u20135.","journal-title":"Br J Neurosurg"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02789-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-022-02789-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02789-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T07:04:42Z","timestamp":1658127882000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-02789-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2789"],"URL":"https:\/\/doi.org\/10.1186\/s12883-022-02789-w","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,18]]},"assertion":[{"value":"22 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The HeMoVal study is conducted in accordance with the Declaration of Helsinki and national and international standards of ICH-GCP E6(R2). Potential participants or their legal representatives receive detailed written and oral information on the study procedures and all participants or their legal representatives provide written informed consent. The study protocol will be approved by the local ethics committees of all participating study sites. At the time of submission, the study protocol has been approved by the ethics committee of the Canton of Zurich, Switzerland (KEK 2021\u201301023) for Zurich (CH), Aarau (CH), and St. Gallen (CH). The HeMoVal study has been registered on August 10, 2021 at , with the identifier NCT04998370.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DS, MH, RMB and KA are inventors on provisional patent applications on the use of haptoglobin and hemopexin in aSAH. This research project is supported by CSL Behring AG, Berne, Switzerland.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"267"}}